EMAGINE 2.0 Trial
122
about 2.2 years
22–80
14 sites in CA, DC, FL +9
What this study is about
This trial is testing a device called the Q Therapeutic System (BQ 3.0) to help people recover after a stroke. The treatment involves using electromagnetic fields to stimulate brain networks and reduce disability. Participants will be randomly assigned to receive either the active treatment or a sham treatment, with follow-up for up to 802 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Q Therapeutic System (BQ 3.0) - Active
- 2.Use Q Therapeutic System (BQ 3.0) - Sham
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Change from Baseline in Modified Rankin Scale
Secondary: 10-meter Walk Test, Change from Baseline in Modified Rankin Scale (Key Secondary Effectiveness Endpoint), Evaluation of 5-level EQ-5D
Neurology